The Tg.AC (v-Ha-ras) Transgenic Mouse: Nature of the Model

By Tennant Raymond W.   Stasiewicz Stanley   Eastin William C.   Mennear John H.   Spalding Judson W.  

Toxicologic Pathology, Vol. 29, Iss. 5, 2001-09 ,pp. : 51-59

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Tumor Spectrum in the p53 Heterozygous Zeta Globin-Promoted Tg.AC (v-Ha-ras) Bitransgenic Mouse Model

By Martin Keith   Jokinen Michael   Honeycutt Hayden   Quinn Anita   Kari Frank   Barrett J.   French John  

Toxicologic Pathology, Vol. 32, Iss. 4, 2004-07 ,pp. : 418-425

Ashgate Publishing Ltd

Access to resources Recommend Favorite

p53^+/- Hemizygous Knockout Mouse: Overview of Available Data

By Storer Richard D.   French John E.   Haseman Joseph   Hajian Gerald   Legrand Edmund K.   Long Gerald G.   Mixson Lori A.   Ochoa Ricardo   Sagartz John E.   Soper Keith A.  

Toxicologic Pathology, Vol. 29, Iss. 5, 2001-09 ,pp. : 30-50

Ashgate Publishing Ltd

Access to resources Recommend Favorite

CB6F1-rasH2 Mouse: Overview of Available Data

By Usui Toshimi   Mutai Mamoru   Hisada Shigeru   Takoaka Masaya   Soper Keith A.   McCullough Bruce   Alden Carl  

Toxicologic Pathology, Vol. 29, Iss. 5, 2001-09 ,pp. : 90-108

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Application of Genetically Altered Models as Replacement for the Lifetime Mouse Bioassay in Pharmaceutical Development

By Alden Carl   Smith Peter   Morton Dan  

Toxicologic Pathology, Vol. 30, Iss. 1, 2002-01 ,pp. : 135-138

Ashgate Publishing Ltd

Access to resources Recommend Favorite